CLINICAL_TRIALS
trial_result
· 2019-01-04
Clinical Trial Update: The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders [Phase 2, Phase 3]
Summary
A completed Phase 2/Phase 3 clinical trial evaluating platelet-rich plasma (PRP) for temporomandibular disorders.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Silesia | Conditions: PRP, Temporomandibular Disorder | Phase 2, Phase 3 | Status: COMPLETED